9-15468830-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM1PP3BS2
The ENST00000380733.9(PSIP1):āc.1220A>Cā(p.Lys407Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,454 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.0000089 ( 1 hom. )
Consequence
PSIP1
ENST00000380733.9 missense
ENST00000380733.9 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 7.45
Genes affected
PSIP1 (HGNC:9527): (PC4 and SRSF1 interacting protein 1) Enables DNA-binding transcription factor binding activity; chromatin binding activity; and transcription coactivator activity. Involved in mRNA 5'-splice site recognition and positive regulation of transcription by RNA polymerase II. Located in heterochromatin; nuclear periphery; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM1
In a mutagenesis_site Reduced interaction with KMT2A. Significant loss of interaction with KMT2A; when associated with A-368. (size 0) in uniprot entity PSIP1_HUMAN
PP3
MetaRNN computational evidence supports a deleterious effect, 0.797
BS2
High AC in GnomAd4 at 22 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSIP1 | NM_033222.5 | c.1220A>C | p.Lys407Thr | missense_variant | 14/16 | ENST00000380733.9 | NP_150091.2 | |
PSIP1 | NM_001128217.3 | c.1220A>C | p.Lys407Thr | missense_variant | 14/16 | NP_001121689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSIP1 | ENST00000380733.9 | c.1220A>C | p.Lys407Thr | missense_variant | 14/16 | 1 | NM_033222.5 | ENSP00000370109 | P1 | |
PSIP1 | ENST00000380738.8 | c.1220A>C | p.Lys407Thr | missense_variant | 14/16 | 1 | ENSP00000370114 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152240Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152240
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250178Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135208
GnomAD3 exomes
AF:
AC:
2
AN:
250178
Hom.:
AF XY:
AC XY:
1
AN XY:
135208
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461214Hom.: 1 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726930
GnomAD4 exome
AF:
AC:
13
AN:
1461214
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
726930
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000145 AC: 22AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74374
GnomAD4 genome
AF:
AC:
22
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.1220A>C (p.K407T) alteration is located in exon 14 (coding exon 13) of the PSIP1 gene. This alteration results from a A to C substitution at nucleotide position 1220, causing the lysine (K) at amino acid position 407 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Loss of methylation at K407 (P = 0.0048);Loss of methylation at K407 (P = 0.0048);
MVP
MPC
0.66
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at